The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/31225
StudyName: Eligibility NSCLC NCT00655161
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 30.07.2018
License: Creative Commons BY 4.0

----

Description: 
A Pilot Phase 2 Trial of the Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant S. Cerevisiae Expressing Mutant Ras Protein, as Consolidation Therapy Following Curative Treatment for Stage I-III Non-Small Cell Lung Cancer (NSCLC) With Tumor Sequence Confirmation of K-ras Mutation; ODM derived from: https://clinicaltrials.gov/show/NCT00655161
